Contact this trialFirst, we need to learn more about you.
PPAR agonist
Lanifibranor for Nonalcoholic Steatohepatitis (NASH)
Recruiting1 awardPhase 3
Metairie, Louisiana
This trial is testing a new drug, lanifibranor, to see if it can treat adults with a fatty liver disease called NASH, and who also have liver fibrosis stage 2 or 3.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.